Left Ventricular Noncompaction: A 25-Year Odyssey.

Left Ventricular Noncompaction: A 25-Year Odyssey.

J Am Soc Echocardiogr. 2012 Jan 25;

Authors: Paterick TE, Umland MM, Jan MF, Ammar KA, Kramer C, Khandheria BK, Seward JB, Tajik AJ

Abstract

Left ventricular noncompaction (LVNC) is a cardiomyopathy associated with sporadic or familial disease, the latter having an autosomal dominant mode of transmission. The clinical features associated with LVNC vary from asymptomatic to symptomatic patients, with the potential for heart failure, supraventricular and ventricular arrhythmias, thromboembolic events, and sudden cardiac death. Echocardiography is the diagnostic modality of choice, revealing the pathognomonic features of a thick, bilayered myocardium; prominent ventricular trabeculations; and deep intertrabecular recesses. Widespread use and advances in the technology of echocardiography and cardiac magnetic resonance imaging are increasing awareness of LVNC, and cardiac magnetic resonance imaging is improving the ability to stage the severity of the disease and potential for adverse clinical consequences. Study of LVNC through research in embryology, imaging, and genetics has allowed enormous strides in the understanding of this heterogeneous disease over the past 25 years.

PMID: 22284845 [PubMed - as supplied by publisher]

 

Neonatologists and Echocardiography: Time to Move On.

Neonatologists and Echocardiography: Time to Move On.

J Am Soc Echocardiogr. 2012 Jan 26;

Authors: Mertens L,

PMID: 22284846 [PubMed - as supplied by publisher]

 



Usefulness of the Right Parasternal Approach to Evaluate the Morphology of Atrial Septal Defect for Transcatheter Closure Using Two-Dimensional and Three-Dimensional Transthoracic Echocardiography.

Usefulness of the Right Parasternal Approach to Evaluate the Morphology of Atrial Septal Defect for Transcatheter Closure Using Two-Dimensional and Three-Dimensional Transthoracic Echocardiography.

J Am Soc Echocardiogr. 2012 Jan 28;

Authors: Watanabe N, Taniguchi M, Akagi T, Tanabe Y, Toh N, Kusano K, Ito H, Koide N, Sano S

Abstract

BACKGROUND: The aim of this study was to demonstrate the feasibility and usefulness of addition of the right parasternal approach to the conventional left parasternal and apical approaches using two-dimensional (2D) and three-dimensional (3D) transthoracic echocardiography (TTE) for morphologic evaluation in cases of transcatheter closure of atrial septal defects (ASDs). METHODS: In 112 consecutive patients with ASDs, the morphology of the defects was evaluated for transcatheter closure in the right parasternal view in addition to the conventional left views using 2D and 3D TTE. Measurements of the maximal ASD diameter and detection of deficient rim obtained on 2D TTE were compared with those obtained by 2D transesophageal echocardiography. The shapes and locations of ASDs visualized by 3D TTE were compared with those visualized by 3D transesophageal echocardiography. RESULTS: In 88 patients (80.0%), optimal images from the right parasternal approach for morphologic evaluation of ASDs were obtained. Although there was a significant difference in maximal ASD diameter obtained only in the conventional left approach compared with transesophageal echocardiographic measurements (P < .05), when the right parasternal approach was applied, a significant difference was not found (P = .18), and the diagnostic concordance of the rim deficiency was improved from 85.2% to 90.9%. Three-dimensional TTE from the right parasternal approach improved visualization of the shape and location of ASDs from 65.5% to 74.5%. CONCLUSIONS: Additional use of the right parasternal approach enables detailed morphologic evaluation for transcatheter closure of ASDs. In patients with suboptimal images on 3D TTE in the left conventional approach, additional 3D TTE in the right parasternal approach can improve the feasibility of obtaining optimal 3D images to evaluate the shapes and locations of ASDs.

PMID: 22285413 [PubMed - as supplied by publisher]

 

Predicting the future in hypertrophic cardiomyopathy: from histopathology to flow to function.

Predicting the future in hypertrophic cardiomyopathy: from histopathology to flow to function.

J Am Soc Echocardiogr. 2012 Feb;25(2):190-3

Authors: Williams L, Rakowski H

PMID: 22270091 [PubMed - in process]

 

Assessment of right ventricular function in targeted neonatal echocardiography: reply to letter by dr. koestenberger and dr. Ravekes.

Assessment of right ventricular function in targeted neonatal echocardiography: reply to letter by dr. koestenberger and dr. Ravekes.

J Am Soc Echocardiogr. 2012 Feb;25(2):244

Authors: Mertens L,

PMID: 22270092 [PubMed - in process]

 



CPT, CMS, RUC, RBRVS: Why This Alphabet Soup-and Filling Out Surveys-Matters to You and Your Practice!

CPT, CMS, RUC, RBRVS: Why This Alphabet Soup-and Filling Out Surveys-Matters to You and Your Practice!

J Am Soc Echocardiogr. 2012 Feb;25(2):A28

Authors:

PMID: 22270094 [PubMed - in process]

 

ASE 2012: Taking the Best of the Past and Making It Better!

ASE 2012: Taking the Best of the Past and Making It Better!

J Am Soc Echocardiogr. 2012 Feb;25(2):A27

Authors:

PMID: 22270093 [PubMed - in process]

 

Keeping current in vascular imaging.

Keeping current in vascular imaging.

J Am Soc Echocardiogr. 2012 Feb;25(2):A31

Authors:

PMID: 22270096 [PubMed - in process]

 

A new career ladder for sonographers.

A new career ladder for sonographers.

J Am Soc Echocardiogr. 2012 Feb;25(2):A30

Authors:

PMID: 22270095 [PubMed - in process]

 

Prevalence and Mechanism of Tricuspid Regurgitation following Implantation of Endocardial Leads for Pacemaker or Cardioverter-Defibrillator.

Prevalence and Mechanism of Tricuspid Regurgitation following Implantation of Endocardial Leads for Pacemaker or Cardioverter-Defibrillator.

J Am Soc Echocardiogr. 2012 Jan 25;

Authors: Al-Mohaissen MA, Chan KL

Abstract

Endocardial lead-induced tricuspid regurgitation has not been well recognized, either clinically or echocardiographically, and yet it is likely a preventable iatrogenic disease. In severe cases, it can lead to right ventricular failure and require tricuspid valve surgery. This complication will become increasingly important, because the numbers of permanent pacemakers and implantable cardioverter-defibrillators are expected to increase because of the aging population and the expanding capabilities of these devices. Published studies are largely retrospective, and serial studies to assess the time course of the development of tricuspid regurgitation are lacking. The mechanisms and severity of tricuspid regurgitation may not be well evaluated by two-dimensional echocardiography. Real-time three-dimensional echocardiography appears to be a promising technique to evaluate the mechanism of tricuspid regurgitation and may allow the early detection of patients who will develop severe lead-induced tricuspid regurgitation. A better understanding of the mechanism of lead-induced tricuspid regurgitation will be essential to the development of preventive strategies, which can then be tested in future clinical trials.

PMID: 22280950 [PubMed - as supplied by publisher]